Does LIPITOR Cause Neoplasm malignant? 20 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 20 reports of Neoplasm malignant have been filed in association with LIPITOR. This represents 0.5% of all adverse event reports for LIPITOR.
20
Reports of Neoplasm malignant with LIPITOR
0.5%
of all LIPITOR reports
6
Deaths
0
Hospitalizations
How Dangerous Is Neoplasm malignant From LIPITOR?
Of the 20 reports, 6 (30.0%) resulted in death.
Is Neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LIPITOR. However, 20 reports have been filed with the FAERS database.
What Other Side Effects Does LIPITOR Cause?
Type 2 diabetes mellitus (2,783)
Drug hypersensitivity (233)
Myalgia (121)
Pain in extremity (82)
Neuropathy peripheral (79)
Muscle spasms (76)
Pain (58)
Death (55)
Muscular weakness (52)
Arthralgia (51)
What Other Drugs Cause Neoplasm malignant?
RANITIDINE (10,648)
ADALIMUMAB (2,028)
APIXABAN (1,772)
ETANERCEPT (1,616)
METHOTREXATE (1,041)
TOFACITINIB (1,020)
RITUXIMAB (929)
INFLIXIMAB (892)
ABATACEPT (727)
RISANKIZUMAB-RZAA (715)
Which LIPITOR Alternatives Have Lower Neoplasm malignant Risk?
LIPITOR vs LIRAGLUTIDE
LIPITOR vs LISDEXAMFETAMINE
LIPITOR vs LISDEXAMFETAMINE DIMESYLATE
LIPITOR vs LISINOPRIL
LIPITOR vs LISOCABTAGENE MARALEUCEL